JP2005120027A - 5-benzyloxy-1,2,3,4-tetrahydronaphthalene derivative and method for producing the same - Google Patents

5-benzyloxy-1,2,3,4-tetrahydronaphthalene derivative and method for producing the same Download PDF

Info

Publication number
JP2005120027A
JP2005120027A JP2003357229A JP2003357229A JP2005120027A JP 2005120027 A JP2005120027 A JP 2005120027A JP 2003357229 A JP2003357229 A JP 2003357229A JP 2003357229 A JP2003357229 A JP 2003357229A JP 2005120027 A JP2005120027 A JP 2005120027A
Authority
JP
Japan
Prior art keywords
benzyloxy
tetrahydronaphthalene
carboxylic acid
optically active
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003357229A
Other languages
Japanese (ja)
Other versions
JP2005120027A5 (en
JP4527379B2 (en
Inventor
Seigou Ishibuchi
正剛 石渕
Mitsuharu Nakamura
光治 中村
Rikizo Furuya
力三 古矢
Mitsuharu Sano
光春 佐野
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Pharma Corp
Original Assignee
Mitsubishi Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Pharma Corp filed Critical Mitsubishi Pharma Corp
Priority to JP2003357229A priority Critical patent/JP4527379B2/en
Publication of JP2005120027A publication Critical patent/JP2005120027A/en
Publication of JP2005120027A5 publication Critical patent/JP2005120027A5/ja
Application granted granted Critical
Publication of JP4527379B2 publication Critical patent/JP4527379B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To solve the problems wherein a well-known method for producing an important intermediate is insufficient for a large-scale industrial production in a cost field and an environmental field because an expensive trimethylsilyl cyanide is used in the process, and further a compound of tin which is a heavy metal is used. <P>SOLUTION: The production method for obtaining optically pure 5-benzyloxy-1,2,3,4-tetrahydronaphthalene-1-carboxylic acid through 5-benzyloxy-1,2,3,4-tetrahydronaphthalene-1-carbonitrile involves using an inexpensive reaction reagent easily made harmless. <P>COPYRIGHT: (C)2005,JPO&NCIPI

Description

本発明は、医薬品の中間体として有用な5−ベンジルオキシ−1,2,3,4−テトラヒドロナフタレン誘導体、及びその製造法に関する。   The present invention relates to a 5-benzyloxy-1,2,3,4-tetrahydronaphthalene derivative useful as a pharmaceutical intermediate and a method for producing the same.

C5a受容体拮抗作用を有するアミド誘導体またはその塩が、国際公開公報に記載されている(特許文献1参照)。当該公報に記載されている5−ヒドロキシ−1,2,3,4−テトラヒドロナフタレン−1−カルボキサミド誘導体を合成する際の重要中間体として、5−ベンジルオキシ−1,2,3,4−テトラヒドロナフタレン−1−カルボン酸(下記式中、I)ならびにその製造方法として、調製例6(調製例5を引用)に下記の方法が開示されている。   An amide derivative having a C5a receptor antagonistic action or a salt thereof is described in International Publication (see Patent Document 1). As an important intermediate in the synthesis of 5-hydroxy-1,2,3,4-tetrahydronaphthalene-1-carboxamide derivatives described in the publication, 5-benzyloxy-1,2,3,4-tetrahydro As naphthalene-1-carboxylic acid (in the following formula, I) and its production method, the following method is disclosed in Preparation Example 6 (quoting Preparation Example 5).

Figure 2005120027
Figure 2005120027

上記公報に開示されている重要中間体の製造方法は、その工程において高価なトリメチルシリルシアニドを使用しており、更には重金属のスズ化合物も使用していることから、スケールの大きな工業的製造には不十分なものである。   The method for producing an important intermediate disclosed in the above publication uses an expensive trimethylsilyl cyanide in the process, and further uses a tin compound of a heavy metal. Is inadequate.

更に、別法として国際公開WO02/22556号公報の一般記載では、方法10に   Furthermore, as a separate method, the general description of International Publication No. WO02 / 22556 includes Method 10

Figure 2005120027
Figure 2005120027

とあるが、この工程を用いて重要中間体である5−ベンジルオキシ−1,2,3,4−テトラヒドロナフタレン−1−カルボン酸を合成した具体的実施例はない。 However, there is no specific example in which 5-benzyloxy-1,2,3,4-tetrahydronaphthalene-1-carboxylic acid, which is an important intermediate, was synthesized using this process.

また、医薬品として不斉炭素を有する化合物を開発する場合、その光学活性体を用いれば、その薬効がさらに向上し副作用等の毒性も軽減されることが予想される。したがって、不斉炭素を有する医薬品を開発しようとする場合、その光学活性体を安価に製造することは極めて重要な問題となり、その合成方法として光学活性な中間体を用いることができれば、更に有用である。しかし、国際公開WO02/22556号公報には、上記、C5a受容体拮抗作用を有する5−ヒドロキシ−1,2,3,4−テトラヒドロナフタレン−1−カルボキサミド誘導体を、光学活性な中間体5−ベンジルオキシ−1,2,3,4−テトラヒドロナフタレン−1−カルボン酸を用いて合成する旨の記載はない。   In addition, when developing a compound having an asymmetric carbon as a pharmaceutical, if the optically active substance is used, it is expected that its medicinal effect is further improved and toxicity such as side effects is reduced. Therefore, when it is intended to develop a pharmaceutical having an asymmetric carbon, it is extremely important to produce the optically active substance at a low cost, and it is more useful if an optically active intermediate can be used as the synthesis method. is there. However, International Publication No. WO02 / 22556 discloses 5-hydroxy-1,2,3,4-tetrahydronaphthalene-1-carboxamide derivative having C5a receptor antagonistic activity as an optically active intermediate 5-benzyl. There is no description of synthesis using oxy-1,2,3,4-tetrahydronaphthalene-1-carboxylic acid.

以上より、C5a受容体拮抗作用を有する5−ヒドロキシ−1,2,3,4−テトラヒドロナフタレン−1−カルボキサミド誘導体の光学活性体の合成における重要中間体である5−ベンジルオキシ−1,2,3,4−テトラヒドロナフタレン−1−カルボン酸のより工業的な製造方法が望まれており、更にその光学活性体の製造方法として、収率、純度(光学純度も含む)、安全性、簡便性などの点でよりすぐれた、環境志向型の工業的大量規模での生産に適した効率のよい製造方法の確立が切望されている。
国際公開WO02/22556号
From the above, 5-benzyloxy-1,2, which is an important intermediate in the synthesis of optically active 5-hydroxy-1,2,3,4-tetrahydronaphthalene-1-carboxamide derivatives having C5a receptor antagonistic activity A more industrial production method of 3,4-tetrahydronaphthalene-1-carboxylic acid is desired, and as a production method of the optically active substance, yield, purity (including optical purity), safety, and simplicity There is an urgent need to establish an efficient manufacturing method suitable for production on an environmentally-oriented industrial mass scale, which is superior in such points.
International Publication WO02 / 22556

国際公開WO02/22556号公報に開示されている重要中間体として有用な5−ベンジルオキシ−1,2,3,4−テトラヒドロナフタレン−1−カルボン酸の製造方法は、その工程において高価なトリメチルシリルシアニドを使用しており、更には重金属のスズ化合物も使用していることから、コスト面、又環境面においてスケールの大きな工業的製造には不十分なものである。   A method for producing 5-benzyloxy-1,2,3,4-tetrahydronaphthalene-1-carboxylic acid useful as an important intermediate disclosed in International Publication No. WO02 / 22556 is an expensive trimethylsilyl cyanate in the process. Since nido is used and also a heavy metal tin compound is used, it is insufficient for industrial production with a large scale in terms of cost and environment.

そこで、5−ベンジルオキシ−1,2,3,4−テトラヒドロナフタレン−1−カルボン酸の製造方法として、安価で無害化の容易な反応剤を使用することにより、工業的製造に適した製造方法を提供することを目的とする。   Therefore, as a method for producing 5-benzyloxy-1,2,3,4-tetrahydronaphthalene-1-carboxylic acid, a production method suitable for industrial production by using an inexpensive and easily detoxifying reagent. The purpose is to provide.

更に、5−ヒドロキシ−1,2,3,4−テトラヒドロナフタレン−1−カルボキサミド誘導体の光学活性体の合成に必須な、光学的に純粋な5−ベンジルオキシ−1,2,3,4−テトラヒドロナフタレン−1−カルボン酸の光学活性体を提供することを目的とする。   Furthermore, optically pure 5-benzyloxy-1,2,3,4-tetrahydro, essential for the synthesis of optically active forms of 5-hydroxy-1,2,3,4-tetrahydronaphthalene-1-carboxamide derivatives. An object is to provide an optically active form of naphthalene-1-carboxylic acid.

本発明者らは、国際公開WO02/22556号公報に開示されているC5a受容体拮抗作用を有する5−ヒドロキシ−1,2,3,4−テトラヒドロナフタレン−1−カルボキサミド誘導体の重要中間体である5−ベンジルオキシ−1,2,3,4−テトラヒドロナフタレン−1−カルボン酸の製造方法を鋭意検討したところ、5−ベンジルオキシ−1,2,3,4−テトラヒドロナフタレン−1−カルボニトリルを経由する工業的に有用な製造方法を見出し、更に、光学活性なアミン、好ましくは1−フェニルエチルアミンの光学活性体を用いた簡便な光学分割方法によって光学活性な5−ベンジルオキシ−1,2,3,4−テトラヒドロナフタレン−1−カルボン酸を、安価で安全で、かつ効率的に製造する方法を確立した。   The present inventors are important intermediates of 5-hydroxy-1,2,3,4-tetrahydronaphthalene-1-carboxamide derivatives having C5a receptor antagonistic activity disclosed in International Publication WO02 / 22556. As a result of intensive studies on a method for producing 5-benzyloxy-1,2,3,4-tetrahydronaphthalene-1-carboxylic acid, 5-benzyloxy-1,2,3,4-tetrahydronaphthalene-1-carbonitrile was obtained. An industrially useful production method is found, and optically active 5-benzyloxy-1,2,2 is obtained by a simple optical resolution method using an optically active amine, preferably an optically active form of 1-phenylethylamine. A method has been established for producing 3,4-tetrahydronaphthalene-1-carboxylic acid inexpensively, safely and efficiently.

即ち、本発明は以下の通りである。
1. 5−ヒドロキシ−1−テトラロンを出発物質に、下記式中の中間体を経由することを特徴とする、5−ベンジルオキシ−1,2,3,4−テトラヒドロナフタレン−1−カルボン酸の製造法。
That is, the present invention is as follows.
1. A process for producing 5-benzyloxy-1,2,3,4-tetrahydronaphthalene-1-carboxylic acid, characterized by passing 5-hydroxy-1-tetralone as a starting material and an intermediate in the following formula .

Figure 2005120027
Figure 2005120027

[式中、Lはハロゲン、メタンスルホニルオキシまたはトルエンスルホニルオキシの脱離基を示す。]
2. 5−ベンジルオキシ−1,2,3,4−テトラヒドロナフタレン−1−カルボン酸と光学活性なアミンによって塩を形成させ、その塩の溶媒に対する溶解度差を用い当該塩の結晶を析出させ分取し、更に酸で処理して光学活性な5−ベンジルオキシ−1,2,3,4−テトラヒドロナフタレン−1−カルボン酸を製造する方法。
3. 上記2において、光学活性なアミンとして(R)−(+)−1−フェニルエチルアミンを用いて、(−)−5−ベンジルオキシ−1,2,3,4−テトラヒドロナフタレン−1−カルボン酸を製造する方法。
4. 5−ベンジルオキシ−1−クロロ−1,2,3,4−テトラヒドロナフタレン
5. 5−ベンジルオキシ−1,2,3,4−テトラヒドロナフタレン−1−カルボニトリル
6. (−)−5−ベンジルオキシ−1,2,3,4−テトラヒドロナフタレン−1−カルボン酸
[Wherein L represents a leaving group for halogen, methanesulfonyloxy or toluenesulfonyloxy. ]
2. A salt is formed with 5-benzyloxy-1,2,3,4-tetrahydronaphthalene-1-carboxylic acid and an optically active amine, and crystals of the salt are precipitated and separated using the difference in solubility of the salt with respect to the solvent. And a method of producing optically active 5-benzyloxy-1,2,3,4-tetrahydronaphthalene-1-carboxylic acid by further treatment with an acid.
3. In (2) above, (R)-(+)-1-phenylethylamine is used as the optically active amine, and (-)-5-benzyloxy-1,2,3,4-tetrahydronaphthalene-1-carboxylic acid is converted to How to manufacture.
4). 5-benzyloxy-1-chloro-1,2,3,4-tetrahydronaphthalene; 5-benzyloxy-1,2,3,4-tetrahydronaphthalene-1-carbonitrile; (−)-5-Benzyloxy-1,2,3,4-tetrahydronaphthalene-1-carboxylic acid


C5a受容体拮抗作用を有する5−ヒドロキシ−1,2,3,4−テトラヒドロナフタレン−1−カルボキサミド誘導体の重要中間体である5−ベンジルオキシ−1,2,3,4−テトラヒドロナフタレン−1−カルボン酸の製造方法として、5−ベンジルオキシ−1,2,3,4−テトラヒドロナフタレン−1−カルボニトリルを経由することにより、その工程において高価なトリメチルシリルシアニドを使用せず、更に重金属のスズ化合物も使用しない、安価で安全で、かつ効率的な製造法を確立した。

5-Benzyloxy-1,2,3,4-tetrahydronaphthalene-1-, which is an important intermediate of 5-hydroxy-1,2,3,4-tetrahydronaphthalene-1-carboxamide derivatives having C5a receptor antagonistic activity By using 5-benzyloxy-1,2,3,4-tetrahydronaphthalene-1-carbonitrile as a method for producing carboxylic acid, no expensive trimethylsilylcyanide is used in the process, and a heavy metal tin is used. Established an inexpensive, safe and efficient production method that does not use compounds.

更に、光学活性なアミンを用いた簡便な光学分割を行うことにより、簡便で、収率、純度(光学純度も含む)も良く、環境志向型の工業的大量規模での生産に適した効率のよい5−ベンジルオキシ−1,2,3,4−テトラヒドロナフタレン−1−カルボン酸の光学活性体を製造する方法を確立した。   Furthermore, by performing simple optical resolution using an optically active amine, it is simple, has good yield and purity (including optical purity), and has an efficiency suitable for production on an environmentally-oriented industrial mass scale. A method for producing a good optically active form of 5-benzyloxy-1,2,3,4-tetrahydronaphthalene-1-carboxylic acid was established.

本明細書において、各記号の定義は次の通りである。   In this specification, the definition of each symbol is as follows.

Lにおけるハロゲンとは、塩素、臭素、ヨウ素を示す。
製造法1
The halogen in L represents chlorine, bromine and iodine.
Manufacturing method 1

Figure 2005120027
Figure 2005120027

[式中の記号は前記と同義である。]
本発明の化合物(I)は化合物(II)より工程1−5を経て製造することができる。
[The symbols in the formula are as defined above. ]
Compound (I) of the present invention can be produced from compound (II) through steps 1-5.

工程1のベンジル基の導入は、Theodora W. Greene、Peter G. M. Wuts編「PROTECTIVE GROUP IN ORGANIC SYNTHESIS」(John Wiley & Sons,Inc.(1991))に記載の方法などで行うことができる。例えば、ベンジルハライドを反応を阻害しない溶媒中、水素化ナトリウム、炭酸ナトリウム、炭酸カリウム、炭酸水素ナトリウム、水酸化ナトリウム、水酸化カリウム、水酸化バリウム、ナトリウムメトキシド、ナトリウムエトキシド、カリウムtert−ブトキシド、トリエチルアミン、ピリジンなどの塩基存在下、−20℃から溶媒の還流温度にて行われる。また、用いられる溶媒としては、ヘキサン、ベンゼン、トルエンなどの炭化水素類、クロロホルム、ジクロロメタン、ジクロロエタンなどのハロゲン化炭化水素類、テトラヒドロフラン、ジオキサンなどのエーテル類、酢酸エステルなどのエステル類、アセトン、メチルエチルケトンなどのケトン類、メタノール、エタノール、イソプロピルアルコールなどのアルコール類、ジメチルホルムアミド、ジメチルアセタミドなどのアミド類、アセトニトリル、ジメチルスルホキシド、水およびこれらの混合溶媒などがあげられ、反応に応じて適宜選択することができる。   The introduction of the benzyl group in Step 1 is described in Theodora W. Greene, Peter G. M.M. It can be performed by the method described in Wuts edition “PROTECTIVE GROUP IN ORGANIC SYNTHESIS” (John Wiley & Sons, Inc. (1991)). For example, sodium hydride, sodium carbonate, potassium carbonate, sodium bicarbonate, sodium hydroxide, potassium hydroxide, barium hydroxide, sodium methoxide, sodium ethoxide, potassium tert-butoxide in a solvent that does not inhibit the reaction of benzyl halide In the presence of a base such as triethylamine or pyridine, the reaction is carried out at -20 ° C to the reflux temperature of the solvent. Solvents used include hydrocarbons such as hexane, benzene and toluene, halogenated hydrocarbons such as chloroform, dichloromethane and dichloroethane, ethers such as tetrahydrofuran and dioxane, esters such as acetate, acetone and methyl ethyl ketone. Ketones such as methanol, ethanol such as isopropyl alcohol, amides such as dimethylformamide and dimethylacetamide, acetonitrile, dimethyl sulfoxide, water and mixed solvents thereof, etc. can do.

工程2の還元反応に用いられる還元剤としては水素化アルミニウムリチウム、水素化ホウ素ナトリウム、水素化ホウ素リチウム、ジボランなどがあげられる。反応に用いられる溶媒は、水、メタノール、エタノール、プロパノール、エーテル、THF、ジオキサン、酢酸などがあげられ、またはこれらの混合溶媒でも良い。反応温度は溶媒によって異なるが、通常−20℃から80℃であり、反応時間は反応温度によって異なるが、通常1時間から24時間である。   Examples of the reducing agent used in the reduction reaction in Step 2 include lithium aluminum hydride, sodium borohydride, lithium borohydride, diborane and the like. Examples of the solvent used in the reaction include water, methanol, ethanol, propanol, ether, THF, dioxane, acetic acid and the like, or a mixed solvent thereof. Although the reaction temperature varies depending on the solvent, it is usually from −20 ° C. to 80 ° C., and the reaction time varies depending on the reaction temperature, but is usually from 1 hour to 24 hours.

工程3における化合物(V)のLが塩素原子の場合、その反応は通常、不活性溶媒中あるいは無溶媒で塩化チオニル、メタンスルホニルクロリド、パラトルエンスルホニルクロリド、トリフェニルホスフィンの存在下、トリエチルアミン等の有機塩基共存下にて−20℃から80℃にて行われ、用いられる溶媒としては、塩化メチレン、クロロホルム、四塩化炭素、エーテル、ジメチルホルムアミドまたはこれらの混合溶媒等があげられる。また化合物(V)のLがメタンスルホニルオキシ、あるいはパラトルエンスルホニルオキシの場合、その反応は通常、不活性溶媒中あるいは無溶媒でメタンスルホニルクロリド、パラトルエンスルホニルクロリドの存在下、トリエチルアミン等の有機塩基共存下にて−20℃から80℃にて行われ、用いられる溶媒としては、塩化メチレン、クロロホルム、エーテル、ジメチルホルムアミドまたはこれらの混合溶媒等があげられる。   When L of compound (V) in Step 3 is a chlorine atom, the reaction is usually carried out in an inert solvent or without solvent in the presence of thionyl chloride, methanesulfonyl chloride, paratoluenesulfonyl chloride, triphenylphosphine, and the like. The reaction is carried out at −20 ° C. to 80 ° C. in the presence of an organic base, and examples of the solvent used include methylene chloride, chloroform, carbon tetrachloride, ether, dimethylformamide, and mixed solvents thereof. When L of compound (V) is methanesulfonyloxy or paratoluenesulfonyloxy, the reaction is usually an organic base such as triethylamine in the presence of methanesulfonyl chloride or paratoluenesulfonyl chloride in an inert solvent or without solvent. The reaction is carried out at −20 ° C. to 80 ° C. in the coexistence, and examples of the solvent used include methylene chloride, chloroform, ether, dimethylformamide, and mixed solvents thereof.

工程4は、反応を阻害しない溶媒中、シアン化ナトリウム、シアン化カリウム、テトラエチルアンモニウムシアニドなどの存在下、−20℃から溶媒の還流温度にて行われる。工程4に用いられる溶媒としては、水、メタノール、エタノール、プロパノール、エチルエーテル、ジメチルホルムアミド、ジメチルスルホキシド、アセトン、アセトニトリルまたはこれらの混合溶媒等があげられる。   Step 4 is performed at −20 ° C. to the reflux temperature of the solvent in the presence of sodium cyanide, potassium cyanide, tetraethylammonium cyanide, etc. in a solvent that does not inhibit the reaction. Examples of the solvent used in Step 4 include water, methanol, ethanol, propanol, ethyl ether, dimethylformamide, dimethyl sulfoxide, acetone, acetonitrile, or a mixed solvent thereof.

工程5は、反応を阻害しない溶媒中、水酸化ナトリウム、水酸化カリウム、水酸化バリウムなどの無機塩基あるいは塩酸、臭化水素酸、硫酸などの酸存在下、−20℃から溶媒の還流温度にて行われる。工程5に用いられる溶媒としては、水、メタノール、エタノール、プロパノール、エチレングリコール、エチレングリコールモノメチルエーテル、ジメチルエーテル、酢酸、ギ酸またはこれらの混合溶媒等があげられる。   Step 5 is carried out from −20 ° C. to the reflux temperature of the solvent in the presence of an inorganic base such as sodium hydroxide, potassium hydroxide, barium hydroxide or an acid such as hydrochloric acid, hydrobromic acid, sulfuric acid, etc., in a solvent that does not inhibit the reaction. Done. Examples of the solvent used in Step 5 include water, methanol, ethanol, propanol, ethylene glycol, ethylene glycol monomethyl ether, dimethyl ether, acetic acid, formic acid, or a mixed solvent thereof.


製造法2(光学分割)
5−ベンジルオキシ−1,2,3,4−テトラヒドロナフタレン−1−カルボン酸(I)の光学活性体は、ラセミ混合物を光学分割することによって得ることができる。例えば、光学活性なアミンと塩を形成させ、溶媒に対する塩の溶解度差を利用して分離することができる。この場合、より難溶性の一方の塩を優先的に晶析させるために、反応液を所定の晶析温度に冷却して過飽和状態とすることが好ましい。

Manufacturing method 2 (Optical resolution)
The optically active form of 5-benzyloxy-1,2,3,4-tetrahydronaphthalene-1-carboxylic acid (I) can be obtained by optical resolution of a racemic mixture. For example, a salt can be formed with an optically active amine, and separation can be performed using the difference in solubility of the salt in the solvent. In this case, in order to preferentially crystallize one of the less soluble salts, it is preferable to cool the reaction solution to a predetermined crystallization temperature to bring it into a supersaturated state.

光学活性なアミンとは、(3S)−(−)−3−アミノピロリジン、(3R)−(+)−3−アミノピロリジン、(1R、2S)−(−)−2−アミノ−1,2−ジフェニルエタノール、(1S、2R)−(+)−2−アミノ−1,2−ジフェニルエタノール、(D)−(−)−アルギニン、(L)−(+)−アルギニン、(+)−cis−2−ベンジルアミノシクロヘキサンメタノール、(−)−cis−2−ベンジルアミノシクロヘキサンメタノール、ブルシン、シンコニジン、シンコニン、(R)−α−メチル−4―ニトロベンジルアミン、(S)−α−メチル−4―ニトロベンジルアミン、(R)−(+)−1−フェニルエチルアミン、(S)−(−)−1−フェニルエチルアミン、(R)−(+)−1−(p−トリル)エチルアミン、(S)−(−)−1−(p−トリル)エチルアミン、(R)−(+)−2−ピロリジンメタノール、(S)−(+)−2−ピロリジンメタノール、(1R、2R)−(−)−2−アミノ−1−(4−ニトロフェニル)−1,3−プロパンジオール、(1S、2S)−(+)−2−アミノ−1−(4−ニトロフェニル)−1,3−プロパンジオールなどが挙げられ、(R)−(+)−1−フェニルエチルアミンが好ましい。   The optically active amine is (3S)-(−)-3-aminopyrrolidine, (3R)-(+)-3-aminopyrrolidine, (1R, 2S)-(−)-2-amino-1,2 -Diphenylethanol, (1S, 2R)-(+)-2-amino-1,2-diphenylethanol, (D)-(-)-arginine, (L)-(+)-arginine, (+)-cis 2-benzylaminocyclohexanemethanol, (-)-cis-2-benzylaminocyclohexanemethanol, brucine, cinchonidine, cinchonine, (R) -α-methyl-4-nitrobenzylamine, (S) -α-methyl-4 -Nitrobenzylamine, (R)-(+)-1-phenylethylamine, (S)-(-)-1-phenylethylamine, (R)-(+)-1- (p-tolyl) ethylamine, S)-(-)-1- (p-tolyl) ethylamine, (R)-(+)-2-pyrrolidinemethanol, (S)-(+)-2-pyrrolidinemethanol, (1R, 2R)-(- ) -2-Amino-1- (4-nitrophenyl) -1,3-propanediol, (1S, 2S)-(+)-2-amino-1- (4-nitrophenyl) -1,3-propane Examples include diol, and (R)-(+)-1-phenylethylamine is preferable.

好ましい溶媒としては、メタノール、エタノール、イソプルピルアルコール等のアルコール類、酢酸エチル、ヘキサン、ヘプタン、アセトン、アセトニトリル、エチルエーテル、イソプロピルエーテル、テトラヒドロフラン、水またはこれらの混合溶媒等があげられる。   Preferable solvents include alcohols such as methanol, ethanol and isopropyl alcohol, ethyl acetate, hexane, heptane, acetone, acetonitrile, ethyl ether, isopropyl ether, tetrahydrofuran, water or a mixed solvent thereof.

好ましい晶析温度は用いる溶媒の量、溶媒の種類、溶解温度によって異なるが、通常−20から80℃の範囲である。   The preferred crystallization temperature varies depending on the amount of solvent used, the type of solvent, and the dissolution temperature, but is usually in the range of -20 to 80 ° C.

なお、一方の塩を晶析させるに際して、その晶析させるべき塩の極少量の結晶を、種結晶として反応液に添加することもできる。   When crystallizing one of the salts, a very small amount of crystals of the salt to be crystallized can be added as seed crystals to the reaction solution.

析出した塩は、遠心分離、濾過、加圧濾過などの一般的な手法により単離することができる。さらに、必要に応じ、再結晶を繰り返すことによって光学純度を向上させることもできる。   The precipitated salt can be isolated by general techniques such as centrifugation, filtration, and pressure filtration. Furthermore, if necessary, the optical purity can be improved by repeating recrystallization.

得られた塩を酸で処理するなどの常法に従うことによって、化合物(I)の光学活性体が得られる。   The optically active form of compound (I) can be obtained by following a conventional method such as treatment of the obtained salt with an acid.

以下に実施例を挙げて本発明をより具体的に説明するが、本発明はこれらに限定されるものではない。   Hereinafter, the present invention will be described more specifically with reference to examples. However, the present invention is not limited to these examples.

なお、H−NMRは270MHzで測定した。H−NMRのケミカルシフト値は、内部標準としてテトラメチルシラン(TMS)を用い、相対的なデルタ(δ)値をパーツパーミリオン(ppm)で表した。カップリング定数は自明な多重度をヘルツ(Hz)で示し、s(シングレット)、d(ダブレット)、t(トリプレット)、m(マルチプレット)等と表記した。 1 H-NMR was measured at 270 MHz. For chemical shift values of 1 H-NMR, tetramethylsilane (TMS) was used as an internal standard, and relative delta (δ) values were expressed in parts per million (ppm). Coupling constants indicate trivial multiplicity in hertz (Hz) and are expressed as s (singlet), d (doublet), t (triplet), m (multiplet), and the like.

化学純度、光学純度は、以下に示す条件下での高速液体クロマトグラフィーを用い決定した。
高速液体クロマトグラフィー
カラム:STR ODS−II(信和化工(株)社製、内径:4.6mm、カラム長:150mm)
移動層:0.05mol/L NaClO(pH2.5):CHCN=4:7
流速:1.0mL/min
温度:室温
検出波長:235nm

カラム:CHIRALCEL OJ−RH(ダイセル化学工業(株)社製、内径:4.6mm、カラム長:150mm)
移動層:0.2mol/L KHPO(pH2.1):CHCN=55:45
流速:0.5mL/min
温度:室温
検出波長:220nm

実施例1
5−ヒドロキシ−1−テトラロン200g(1.23mol)にジメチルホルムアミド600mLを加え溶解させた中に氷冷しながら5〜15℃でカリウムtert−ブトキシド159.1g(1.41mol)を少量づつ加えたのち、室温で1時間攪拌した。反応液を氷冷し5〜12℃でベンジルブロミド243g(1.41mol)を滴下したのち、室温で2時間攪拌した。反応混液を氷水中に注ぎ酢酸エチル1Lで抽出したのち、水洗し、硫酸マグネシウムで乾燥した。酢酸エチル溶液を減圧濃縮して油状の5−ベンジルオキシ−1−テトラロン327g(理論量310g)を得た。
Chemical purity and optical purity were determined using high performance liquid chromatography under the following conditions.
High-performance liquid chromatography column: STR ODS-II (manufactured by Shinwa Kako Co., Ltd., inner diameter: 4.6 mm, column length: 150 mm)
Moving layer: 0.05 mol / L NaClO 4 (pH 2.5): CH 3 CN = 4: 7
Flow rate: 1.0 mL / min
Temperature: Room temperature Detection wavelength: 235nm

Column: CHIRALCEL OJ-RH (manufactured by Daicel Chemical Industries, Ltd., inner diameter: 4.6 mm, column length: 150 mm)
Moving layer: 0.2 mol / L KH 2 PO 4 (pH 2.1): CH 3 CN = 55: 45
Flow rate: 0.5 mL / min
Temperature: Room temperature Detection wavelength: 220nm

Example 1
To 200 g (1.23 mol) of 5-hydroxy-1-tetralone, 600 mL of dimethylformamide was added and dissolved, and 159.1 g (1.41 mol) of potassium tert-butoxide was added little by little at 5 to 15 ° C. with ice cooling. After that, the mixture was stirred at room temperature for 1 hour. The reaction solution was ice-cooled, and 243 g (1.41 mol) of benzyl bromide was added dropwise at 5 to 12 ° C., followed by stirring at room temperature for 2 hours. The reaction mixture was poured into ice water, extracted with 1 L of ethyl acetate, washed with water, and dried over magnesium sulfate. The ethyl acetate solution was concentrated under reduced pressure to obtain 327 g (theoretical amount: 310 g) of oily 5-benzyloxy-1-tetralone.

H−NMR(CDCl3)δ:2.05−2.20(2H,m),2.64(2H,t,J=6.6Hz),2.97(2H,t,J=6.6Hz),5.11(2H,s),7.06−7.10(1H,m),7.25(1H,t,J=7.9Hz),7.30−7.50(5H,m),7.65−7.70(1H,m)
実施例2
5−ベンジルオキシ−1−テトラロン(327g)をメタノール2000mLに溶解させ,氷冷しながら8〜13℃で水素化ホウ素ナトリウム32.6g(0.86mol)を少量づつ加えたのち、室温で1時間攪拌した。反応混液を減圧濃縮し、残渣に水2L を加え室温で30分攪拌した。固化した結晶を濾取したのち、イソプロピルアルコール500mLを加え、60℃に加温し溶解した中にn−ヘキサン1.5Lを加え氷冷下で1時間攪拌した。析出した固体を濾取後、60℃で終夜送風乾燥して微黄白色結晶の5−ベンジルオキシ−1−ヒドロキシ−1,2,3,4−テトラヒドロナフタレン237gを得た。濾液は減圧濃縮し、イソプロピルアルコール/n−ヘキサン=1/3(350ml)を加えて氷冷し、析出した固体を濾取後、60℃で終夜送風乾燥して5−ベンジルオキシ−1−ヒドロキシ−1,2,3,4−テトラヒドロナフタレンの二番結晶 42.8gを得た(5−ヒドロキシ−1−テトラロンからの総収率90%)。
融点75−77℃
H−NMR(CDCl3)δ:1.70−2.05(4H,m),2.55−2.70(1H,m),2.80−2.92(1H,m),4.70−4.80(1H,m),5.07(2H,s),6.82(1H,d,J=7.9Hz),7.08(1H,d,J=7.9Hz),7.18(1H,t,J=7.9Hz),7.25−7.50(5H,m)
実施例3
5−ベンジルオキシ−1−ヒドロキシ−1,2,3,4−テトラヒドロナフタレン150g(0.59mol)を塩化メチレン450mLに溶解させ,氷冷しながら5〜12℃で塩化チオニル51mL(0.708mol)を滴下し,氷冷下で30分、次いで室温で2.5時間攪拌した。反応混液を氷水中に注ぎ、水洗、硫酸マグネシウムで乾燥したのち,塩化メチレン溶液を減圧濃縮して油状(室温で固化)の5−ベンジルオキシ−1−クロロ−1,2,3,4−テトラヒドロナフタレン163g(理論量161g)を得た。
融点74℃
H−NMR(CDCl3)δ:1.80−1.95(1H,m),2.00−2.35(3H,m),2.45−2.65(1H,m),2.90−3.05(1H,m),5.05(2H,s),5.29(1H,t,J=3.3Hz),6.80(1H,d,J=7.9Hz),7.00(1H,d,J=7.9Hz),7.14(1H,t,J=7.9Hz),7.25−7.50(5H,m)
実施例4
シアン化ナトリウム57.8g(1.18mol)をジメチルスルホキシド480mLに加え、65℃に加温し溶解させた中に5−ベンジルオキシ−1−クロロ−1,2,3,4−テトラヒドロナフタレン163gとジメチルスルホキシド160mLの溶液を62〜63℃で滴下したのち、65℃で4.5時間攪拌した。反応混液を氷水中に注ぎ酢酸エチル800mLで抽出したのち、水洗し、硫酸マグネシウムで乾燥した。酢酸エチル溶液を減圧濃縮して油状の5−ベンジルオキシ−1,2,3,4−テトラヒドロナフタレン−1−カルボニトリル154g(理論量155g)を得た。
H−NMR(CDCl3)δ:1.76−1.92(1H,m),1.95−2.15(3H,m),2.70−2.90(2H,m),3.97(1H,t,J=5.9Hz),5.07(2H,s),6.83(1H,d,J=7.9Hz),6.99(1H,d,J=7.9Hz),7.17(1H,t,J=7.9Hz),7.25−7.45(5H,m)
実施例5
5−ベンジルオキシ−1,2,3,4−テトラヒドロナフタレン−1−カルボニトリル154gにエチレングリコール144mLを加え、室温で攪拌しながら水酸化カリウム(純度85%)60.0g(0.909mol)を少量づつ加えたのち、3時間攪拌還流した。反応混液を氷水中に注ぎ酢酸エチル200mLで3回洗浄したのち、水層を2N−塩酸でpH1とし析出した固体を濾取後、60℃で終夜送風乾燥して褐色結晶の5−ベンジルオキシ−1,2,3,4−テトラヒドロナフタレン−1−カルボン酸103gを得た(5−ベンジルオキシ−1−ヒドロキシ−1,2,3,4−テトラヒドロナフタレンからの総収率62%)。
融点144℃
H−NMR(CDCl3)δ:1.70−2.05(3H,m),2.10−2.25(1H,m),2.60−2.90(2H,m),3.84(1H,t,J=5.3Hz),5.05(2H,s),6.79(1H,d,J=7.9Hz),6.85(1H,d,J=7.9Hz),7.11(1H,t,J=7.9Hz),7.25−7.50(5H,m)
実施例6
5−ベンジルオキシ−1,2,3,4−テトラヒドロナフタレン−1−カルボン酸14.1g(0.05mol)にアセトン65mLを加え、加熱溶解させた中に(R)−(+)−1−フェニルエチルアミン6.05g(0.05mol)を加え氷冷下で攪拌した。析出した固体を濾取して光学純度93.3%の粗結晶7.7gを得た。この粗結晶をアセトン31mLに加熱溶解させたのち、氷冷下で攪拌し、析出した固体を濾取後、60℃で終夜送風乾燥して(−)−5−ベンジルオキシ−1,2,3,4−テトラヒドロナフタレン−1−カルボン酸の(R)−(+)−1−フェニルエチルアミン塩6.80g(淡褐色結晶)を得た(収率34%)。
光学純度99.3%e.e.
融点87℃
実施例7
(−)−5−ベンジルオキシ−1,2,3,4−テトラヒドロナフタレン−1−カルボン酸の(R)−(+)−1−フェニルエチルアミン塩6.5g(0.0161mol)にエタノール/水(1/2)32mLを加え、室温で攪拌した中に濃塩酸3.64gとエタノール/水(1/2)9mLの溶液を滴下したのち、室温で1時間攪拌した。反応混液を50℃で1時間攪拌したのち、30分間氷冷し、析出した固体を濾取後、60℃で終夜送風乾燥して淡褐色結晶の(−)−5−ベンジルオキシ−1,2,3,4−テトラヒドロナフタレン−1−カルボン酸4.36gを得た(収率96%)。
融点96−97℃
化学純度 99.6%
光学純度 99.2%e.e.
1 H-NMR (CDCl 3 ) δ: 2.05-2.20 (2H, m), 2.64 (2H, t, J = 6.6 Hz), 2.97 (2H, t, J = 6. 6 Hz), 5.11 (2H, s), 7.06-7.10 (1 H, m), 7.25 (1 H, t, J = 7.9 Hz), 7.30-7.50 (5 H, m), 7.65-7.70 (1H, m)
Example 2
5-Benzyloxy-1-tetralone (327 g) was dissolved in 2000 mL of methanol, and 32.6 g (0.86 mol) of sodium borohydride was added in small portions at 8-13 ° C. with ice cooling, and then at room temperature for 1 hour. Stir. The reaction mixture was concentrated under reduced pressure, 2 L of water was added to the residue, and the mixture was stirred at room temperature for 30 minutes. After the solidified crystals were collected by filtration, 500 mL of isopropyl alcohol was added, and 1.5 L of n-hexane was added to the solution dissolved by heating to 60 ° C., followed by stirring for 1 hour under ice cooling. The precipitated solid was collected by filtration and then dried by air blowing at 60 ° C. overnight to obtain 237 g of 5-benzyloxy-1-hydroxy-1,2,3,4-tetrahydronaphthalene as slightly yellowish white crystals. The filtrate was concentrated under reduced pressure, isopropyl alcohol / n-hexane = 1/3 (350 ml) was added and ice-cooled. The precipitated solid was collected by filtration and then air-dried at 60 ° C. overnight to give 5-benzyloxy-1-hydroxy. 42.8 g of a second crystal of -1,2,3,4-tetrahydronaphthalene was obtained (total yield from 5-hydroxy-1-tetralone 90%)
Melting point 75-77 ° C
1 H-NMR (CDCl 3 ) δ: 1.70-2.05 (4H, m), 2.55-2.70 (1H, m), 2.80-2.92 (1H, m), 4 70-4.80 (1H, m), 5.07 (2H, s), 6.82 (1H, d, J = 7.9 Hz), 7.08 (1H, d, J = 7.9 Hz) 7.18 (1H, t, J = 7.9 Hz), 7.25-7.50 (5H, m)
Example 3
150 g (0.59 mol) of 5-benzyloxy-1-hydroxy-1,2,3,4-tetrahydronaphthalene was dissolved in 450 mL of methylene chloride, and 51 mL (0.708 mol) of thionyl chloride at 5-12 ° C. with ice cooling. Was added dropwise, and the mixture was stirred for 30 minutes under ice-cooling and then for 2.5 hours at room temperature. The reaction mixture is poured into ice water, washed with water and dried over magnesium sulfate, and the methylene chloride solution is concentrated under reduced pressure to give an oily (solidified at room temperature) 5-benzyloxy-1-chloro-1,2,3,4-tetrahydro 163 g of naphthalene (theoretical amount 161 g) was obtained.
Melting point 74 ° C
1 H-NMR (CDCl 3 ) δ: 1.80-1.95 (1H, m), 2.00-2.35 (3H, m), 2.45-2.65 (1H, m), 2 .90-3.05 (1H, m), 5.05 (2H, s), 5.29 (1H, t, J = 3.3 Hz), 6.80 (1H, d, J = 7.9 Hz) , 7.00 (1H, d, J = 7.9 Hz), 7.14 (1H, t, J = 7.9 Hz), 7.25-7.50 (5H, m)
Example 4
57.8 g (1.18 mol) of sodium cyanide was added to 480 mL of dimethyl sulfoxide and heated to 65 ° C. to dissolve it, and 163 g of 5-benzyloxy-1-chloro-1,2,3,4-tetrahydronaphthalene and A solution of 160 mL of dimethyl sulfoxide was added dropwise at 62 to 63 ° C, and then stirred at 65 ° C for 4.5 hours. The reaction mixture was poured into ice water, extracted with 800 mL of ethyl acetate, washed with water, and dried over magnesium sulfate. The ethyl acetate solution was concentrated under reduced pressure to obtain 154 g (theoretical amount: 155 g) of oily 5-benzyloxy-1,2,3,4-tetrahydronaphthalene-1-carbonitrile.
1 H-NMR (CDCl 3 ) δ: 1.76-1.92 (1H, m), 1.95-2.15 (3H, m), 2.70-2.90 (2H, m), 3 .97 (1H, t, J = 5.9 Hz), 5.07 (2H, s), 6.83 (1H, d, J = 7.9 Hz), 6.99 (1H, d, J = 7. 9 Hz), 7.17 (1 H, t, J = 7.9 Hz), 7.25-7.45 (5 H, m)
Example 5
To 154 g of 5-benzyloxy-1,2,3,4-tetrahydronaphthalene-1-carbonitrile was added 144 mL of ethylene glycol, and 60.0 g (0.909 mol) of potassium hydroxide (purity 85%) was stirred at room temperature. After adding a small amount, the mixture was stirred and refluxed for 3 hours. The reaction mixture was poured into ice water and washed three times with 200 mL of ethyl acetate. The aqueous layer was adjusted to pH 1 with 2N-hydrochloric acid, and the precipitated solid was collected by filtration and dried by blowing at 60 ° C. overnight to give 5-benzyloxy- 103 g of 1,2,3,4-tetrahydronaphthalene-1-carboxylic acid was obtained (total yield from 5-benzyloxy-1-hydroxy-1,2,3,4-tetrahydronaphthalene 62%).
Melting point 144 ° C
1 H-NMR (CDCl 3 ) δ: 1.70-2.05 (3H, m), 2.10-2.25 (1H, m), 2.60-2.90 (2H, m), 3 .84 (1H, t, J = 5.3 Hz), 5.05 (2H, s), 6.79 (1H, d, J = 7.9 Hz), 6.85 (1H, d, J = 7. 9 Hz), 7.11 (1 H, t, J = 7.9 Hz), 7.25-7.50 (5 H, m)
Example 6
(R)-(+)-1- In a solution in which 65 mL of acetone was added to 14.1 g (0.05 mol) of 5-benzyloxy-1,2,3,4-tetrahydronaphthalene-1-carboxylic acid and dissolved by heating. 6.05 g (0.05 mol) of phenylethylamine was added and stirred under ice cooling. The precipitated solid was collected by filtration to obtain 7.7 g of crude crystals having an optical purity of 93.3%. The crude crystals were dissolved in 31 mL of acetone by heating and stirred under ice-cooling. The precipitated solid was collected by filtration and then dried by blowing at 60 ° C. overnight to give (−)-5-benzyloxy-1,2,3. , 4-tetrahydronaphthalene-1-carboxylic acid (R)-(+)-1-phenylethylamine salt 6.80 g (light brown crystals) was obtained (yield 34%).
Optical purity 99.3% e.e. e.
Melting point 87 ° C
Example 7
To 6.5 g (0.0161 mol) of (R)-(+)-1-phenylethylamine salt of (−)-5-benzyloxy-1,2,3,4-tetrahydronaphthalene-1-carboxylic acid was added ethanol / water. (1/2) 32 mL was added, and a solution of 3.64 g of concentrated hydrochloric acid and 9 mL of ethanol / water (1/2) was added dropwise thereto while stirring at room temperature, followed by stirring at room temperature for 1 hour. The reaction mixture was stirred at 50 ° C. for 1 hour and then ice-cooled for 30 minutes. The precipitated solid was collected by filtration and then dried by blowing at 60 ° C. overnight to give pale brown crystals of (−)-5-benzyloxy-1,2 , 3,4-tetrahydronaphthalene-1-carboxylic acid 4.36 g was obtained (yield 96%).
Melting point 96-97 ° C
Chemical purity 99.6%
Optical purity 99.2% e.e. e.

C5a受容体拮抗作用を有する5−ヒドロキシ−1,2,3,4−テトラヒドロナフタレン−1−カルボキサミド誘導体の重要中間体である5−ベンジルオキシ−1,2,3,4−テトラヒドロナフタレン−1−カルボン酸の製造方法として、5−ベンジルオキシ−1,2,3,4−テトラヒドロナフタレン−1−カルボニトリルを経由することにより、その工程において高価なトリメチルシリルシアニドを使用せず、更に重金属のスズ化合物も使用しない、安価で安全で、かつ効率的な製造法を確立した。   5-Benzyloxy-1,2,3,4-tetrahydronaphthalene-1-, which is an important intermediate of 5-hydroxy-1,2,3,4-tetrahydronaphthalene-1-carboxamide derivatives having C5a receptor antagonistic activity By using 5-benzyloxy-1,2,3,4-tetrahydronaphthalene-1-carbonitrile as a method for producing carboxylic acid, no expensive trimethylsilylcyanide is used in the process, and a heavy metal tin is used. Established an inexpensive, safe and efficient production method that does not use compounds.

更に、光学活性なアミンを用いた簡便な光学分割を行うことにより、簡便で、収率、純度(光学純度も含む)も良く、環境志向型の工業的大量規模での生産に適した効率のよい5−ベンジルオキシ−1,2,3,4−テトラヒドロナフタレン−1−カルボン酸の光学活性体を製造する方法を確立した。   Furthermore, by performing simple optical resolution using an optically active amine, it is simple, has good yield and purity (including optical purity), and has an efficiency suitable for production on an environmentally-oriented industrial mass scale. A method for producing a good optically active form of 5-benzyloxy-1,2,3,4-tetrahydronaphthalene-1-carboxylic acid was established.

Claims (6)

5−ヒドロキシ−1−テトラロンを出発物質に、下記式中の中間体を経由することを特徴とする、5−ベンジルオキシ−1,2,3,4−テトラヒドロナフタレン−1−カルボン酸の製造法。
Figure 2005120027

[式中、Lはハロゲン、メタンスルホニルオキシまたはトルエンスルホニルオキシの脱離基を示す。]
A process for producing 5-benzyloxy-1,2,3,4-tetrahydronaphthalene-1-carboxylic acid, characterized by passing 5-hydroxy-1-tetralone as a starting material and an intermediate in the following formula .
Figure 2005120027

[Wherein L represents a leaving group for halogen, methanesulfonyloxy or toluenesulfonyloxy. ]
5−ベンジルオキシ−1,2,3,4−テトラヒドロナフタレン−1−カルボン酸と光学活性なアミンによって塩を形成させ、その塩の溶媒に対する溶解度差を用い当該塩の結晶を析出させ分取し、更に酸で処理して光学活性な5−ベンジルオキシ−1,2,3,4−テトラヒドロナフタレン−1−カルボン酸を製造する方法。 A salt is formed with 5-benzyloxy-1,2,3,4-tetrahydronaphthalene-1-carboxylic acid and an optically active amine, and crystals of the salt are precipitated and separated using the difference in solubility of the salt with respect to the solvent. And a method of producing optically active 5-benzyloxy-1,2,3,4-tetrahydronaphthalene-1-carboxylic acid by further treatment with an acid. 請求項2の光学活性なアミンが(R)−(+)−1−フェニルエチルアミンである、(−)−5−ベンジルオキシ−1,2,3,4−テトラヒドロナフタレン−1−カルボン酸を製造する方法。 (-)-5-benzyloxy-1,2,3,4-tetrahydronaphthalene-1-carboxylic acid, wherein the optically active amine of claim 2 is (R)-(+)-1-phenylethylamine how to. 5−ベンジルオキシ−1−クロロ−1,2,3,4−テトラヒドロナフタレン 5-Benzyloxy-1-chloro-1,2,3,4-tetrahydronaphthalene 5−ベンジルオキシ−1,2,3,4−テトラヒドロナフタレン−1−カルボニトリル 5-Benzyloxy-1,2,3,4-tetrahydronaphthalene-1-carbonitrile (−)−5−ベンジルオキシ−1,2,3,4−テトラヒドロナフタレン−1−カルボン酸
(−)-5-Benzyloxy-1,2,3,4-tetrahydronaphthalene-1-carboxylic acid
JP2003357229A 2003-10-17 2003-10-17 5-Benzyloxy-1,2,3,4-tetrahydronaphthalene derivative and process for producing the same Expired - Fee Related JP4527379B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2003357229A JP4527379B2 (en) 2003-10-17 2003-10-17 5-Benzyloxy-1,2,3,4-tetrahydronaphthalene derivative and process for producing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003357229A JP4527379B2 (en) 2003-10-17 2003-10-17 5-Benzyloxy-1,2,3,4-tetrahydronaphthalene derivative and process for producing the same

Publications (3)

Publication Number Publication Date
JP2005120027A true JP2005120027A (en) 2005-05-12
JP2005120027A5 JP2005120027A5 (en) 2006-10-26
JP4527379B2 JP4527379B2 (en) 2010-08-18

Family

ID=34614176

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003357229A Expired - Fee Related JP4527379B2 (en) 2003-10-17 2003-10-17 5-Benzyloxy-1,2,3,4-tetrahydronaphthalene derivative and process for producing the same

Country Status (1)

Country Link
JP (1) JP4527379B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006082975A1 (en) * 2005-02-07 2006-08-10 Mitsubishi Pharma Corporation Optically active tetrahydronaphthalene derivative

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5116651A (en) * 1974-07-31 1976-02-10 Takeda Chemical Industries Ltd Kanjokagobutsuno seizoho
JPS617245A (en) * 1984-06-06 1986-01-13 アボツト ラボラトリーズ Adrenal compound
WO2002022556A1 (en) * 2000-09-14 2002-03-21 Mitsubishi Pharma Corporation Novel amide derivatives and medicinal use thereof ugs

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5116651A (en) * 1974-07-31 1976-02-10 Takeda Chemical Industries Ltd Kanjokagobutsuno seizoho
JPS617245A (en) * 1984-06-06 1986-01-13 アボツト ラボラトリーズ Adrenal compound
WO2002022556A1 (en) * 2000-09-14 2002-03-21 Mitsubishi Pharma Corporation Novel amide derivatives and medicinal use thereof ugs

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006082975A1 (en) * 2005-02-07 2006-08-10 Mitsubishi Pharma Corporation Optically active tetrahydronaphthalene derivative

Also Published As

Publication number Publication date
JP4527379B2 (en) 2010-08-18

Similar Documents

Publication Publication Date Title
JPS60228441A (en) Manufacture of optically active alpha-arylalkanoic acid and novel intermediate
FR2941454A1 (en) PROCESS FOR THE SYNTHESIS OF (1S, 2R) -MILNACIPRAN
JPH05213838A (en) Preparation of fluoxetine
JP3224271B2 (en) Process for the synthesis of enantiomerically pure substituted (quinolin-2-yl-methoxy) -phenylacetic acids
JP2009062360A (en) Method for producing cinacalcet
JPH0231704B2 (en)
JP4527379B2 (en) 5-Benzyloxy-1,2,3,4-tetrahydronaphthalene derivative and process for producing the same
JP2005536558A (en) Process for the production of nitrooxy derivatives of naproxen
US11319277B2 (en) Process for converting S-enantiomer to its racemic form
WO2008078350A2 (en) Process for the preparation of fluorophenylacetic acids and derivatives thereof
EP1008590A1 (en) Process for preparing optically active oxazolidinone derivative
JP2004224764A (en) Method for producing optically active trans-1,2-cyclohexanedicarboxylic acid derivative
JPH0417938B2 (en)
JP2003137835A (en) Method for producing (r)-3-hydroxy-3-(2-phenyl)hexanoic acid
TW457233B (en) Preparation of 3-fluoro oxindole derivatives
JP7128629B2 (en) Method for producing lubiprostone
JP2006298872A (en) Manufacturing method of 1-fluoro-1-phenylthioethene
JP2006169251A (en) Method for producing enantiomerically enriched 2-fluorocarboxylic acid ester
JP6434261B2 (en) Iodobenzamide type alcohol oxidation catalyst
IL295479A (en) Preparation of s-beflubutamid by resolving 2-(4-fluoro-3-(trifluoromethyl)phenoxy)butanoic acid
JPS5946234A (en) Preparation of optically active alcohol
JP2008222597A (en) METHOD FOR PRODUCING beta-FLUOROMETHYLCARBONYL DERIVATIVE
JP2005097158A (en) Method for producing fluorine-containing organic compound
JP4854255B2 (en) 2-Fluorine-containing alkoxy fatty acid ester compound production method
WO2013069481A1 (en) Method for producing triazole compound and intermediate of triazole compound

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060912

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060912

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20070427

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A712

Effective date: 20071102

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20100127

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100216

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100413

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20100601

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20100603

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130611

Year of fee payment: 3

R150 Certificate of patent (=grant) or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees